Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1065 | 1008 | 1077 | 1073 | 1343 | 1953 |
Fund Return | 6.51% | 0.77% | 7.7% | 2.36% | 6.08% | 6.92% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth CAD | 4.34B | 7.61 | 6.76 | 10.05 | ||
Renaissance Global Growth Cl F CAD | 4.34B | 8.20 | 8.15 | 11.50 | ||
Renaissance International Eq Cl CAD | 1.86B | 7.09 | 3.70 | 8.38 | ||
Renaissance US Equity Income F CAD | 1.39B | 7.77 | 8.08 | 10.39 | ||
Renaissance US Eq Income F Pr CAD | 1.39B | 7.80 | 8.14 | 10.52 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mawer International Equity Fund Cla | 7.61B | 7.77 | 2.40 | 6.78 | ||
DFA International Core Equity Class | 3.05B | 9.29 | 5.06 | 6.63 | ||
RBC International Equity Sr F CAD | 2.46B | 12.09 | 5.88 | 8.04 | ||
RBC International Equity Fund D CAD | 2.46B | 11.96 | 5.59 | 7.75 | ||
Sun Life MFS Intl Value A T5 | 2.17B | 12.57 | 3.14 | 7.33 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.40 | 988.4 | +0.45% | |
ASML Holding | NL0010273215 | 3.86 | 963.40 | +0.47% | |
Taiwan Semiconductor | US8740391003 | 3.24 | 168.88 | +2.73% | |
Keyence | JP3236200006 | 3.07 | 70,620.0 | +1.41% | |
Experian | GB00B19NLV48 | 2.66 | 3,650.0 | -0.36% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review